Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recent data feature short-chain fatty acids (SCFAs), products of gut microbial fermentation, as modulators of the blood pressure of the host. Such modulation may evoke (or arise from) changes in the autonomic reflexive mechanisms, but the link remains unexplored. Therefore, the study aims to explore potential relationship between the dietary intervention-induced changes in the SCFA plasma/fecal content and alterations in the sensitivity of the cardio-respiratory autonomic reflexes.
In this cross-over, placebo-controlled study, a group of healthy volunteers will undergo three distinct stages of a four-week dietary intervention, separated by at least two weeks of washout periods. During each stage, participants will receive one of the following interventions:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| potato starch | Experimental |
| |
| sodium butyrate | Experimental |
| |
| accessible maze starch | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Potato starch supplementation | Dietary Supplement | Participants will receive potato starch supplement, undergoing gut microbial fermentation and acting as an endogenous source of the short-chain fatty acids, including butyrate. Effects of these compounds on the selected autonomic functions (i.e. cardio-respiratory control) will be further investigated. |
| Measure | Description | Time Frame |
|---|---|---|
| Arterial baroreflex sensitivity | Arterial baroreflex sensitivity, measured with a neck chamber technique. | From the beginning to the end of a supplementation period at 4 weeks. |
| Peripheral chemoreflex sensitivity | Peripheral chemoreflex sensitivity, measured with the transient hypoxia test. | From the beginning to the end of a supplementation period at 4 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma short-chain fatty acids | Plasma level of short-chain fatty acids, evaluated with high-performance liquid chromatography. | From the beginning to the end of a supplementation period at 4 weeks. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wroclaw Medical University | Wroclaw | Lower Silesian Voivodeship | 50-367 | Poland |
This is a small trial which includes solely healthy volunteers. Therefore, data will not be shared at this instance.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Sodium butyrate supplementation | Dietary Supplement | Participants will receive sodium butyrate supplement, acting as an exogenous source of the short-chain fatty acid butyrate. Effects of such compound on the selected autonomic functions (i.e. cardio-respiratory control) will be further investigated. |
|
| Accessible starch supplementation | Dietary Supplement | Participants will receive the accessible (digestible) waxy maze starch as placebo. |
|